Upperton Pharma Solutions, a contract development and manufacturing organization (CDMO), has completed a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 square foot development and GMP manufacturing facility in Nottingham, UK.
Scientist Spotlight: A Journey of Innovation with Shailesh Mistry
Dry Powder Formulation: The Next Generation
Upperton`s New GMP Facility Officially Opened By Prof Dame Sarah Gilbert
Upperton appoint Philip Payne as Chief Commercial Officer
Upperton Expands Into Sterile Drug Manufacturing With New £5M GMP Facility
Upperton Pharma Solutions, a U.K.-based CDMO, put the finishing touches on a 15 million pound sterling ($19.6 million) expansion of its manufacturing facility near its headquarters in Nottingham.
Upperton Pharma Solutions founder heads to Buckingham Palace for King’s Award honour
Upperton Pharma Solutions, a UK contract development and manufacturing organization (CDMO), has begun construction work for its new development and GMP manufacturing headquarters in Nottingham, UK.